PPCB (Propanc Biopharma Inc) Wutah bathi ing taun lumaku

Simbol resmi perusahaan Propanc Biopharma (PPCB)

The relative annual growth in net income per share for Propanc Biopharma Inc (PPCB) illustrates the effectiveness of enzyme-based therapy designed to block tumor recurrence. This trend reflects the expansion of the PRP pipeline to capture the oncology market while management adapts processes to meet regulatory standards. The current 0.00 figure determines the metric's magnitude, helping investors assess the business's real return amid a sideways market.

PPCB (Propanc Biopharma Inc.) riwayat Wutah bathi ing taun lumaku saka 16.08.2025 nganti 12.11.2026

Rincian metrik komprehensif lan analitis propanc.com (PPCB)

- rega saham lan prakiraan rega para ahli:
Rega Propanc Biopharma|PPCB - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Propanc Biopharma|PPCB - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham Propanc Biopharma|PPCB - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas propanc.com|PPCB - Total Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Propanc Biopharma Inc|PPCB - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Propanc Biopharma|PPCB - Gunggung utang perusahaan|Utang-utang marang nilai buku Propanc Biopharma|PPCB - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Propanc Biopharma|Rasio jangkoan perantara propanc.com
- indikator pendapatan resik lan kelipatan nilai:
PPCB - Penghasilan resik|Bathi resik mangsa ngarep Propanc Biopharma Inc|PPCB - Pangali P/E|Pangali mangsa ngarep rega marang bathi Propanc Biopharma|PPCB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Propanc Biopharma|PPCB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Propanc Biopharma|PPCB - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan propanc.com|PPCB - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Propanc Biopharma Inc
Pambiji fundamental:PPCB Propanc Biopharma, Inc.
Produk mawa merek Propanc Biopharma Inc

To build a high-quality portfolio, I evaluate capital efficiency through the annual change in EPS. This metric measures the growth rate of net income per share, revealing the impact of exchange rates on the dollar value of the business. For Propanc Biopharma Inc (PPCB), such fluctuations are critical amid fierce competition in the oncotherapy sector. The annual percentage dynamics of earnings per share reflect financial resilience against the technological breakthroughs of competitors. By analyzing this chart, an investor determines the risk of development depreciation.

Pesaing langsung

GMAB: Wutah bathi resik saben siji saham kanggo taun lumaku|EXEL (Exelixis Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Nuvalent Therapeutics|Wutah bathi saben saham ing taun lumaku Kymera Therapeutics (KYMR)|IDYA (ideayabio.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ELVN (Enliven Therapeutics, Inc.)|Owah-owahan bathi resik saben saham ing taun lumaku ORIC Pharmaceuticals Inc|Relay Pharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Wutah bathi resik saben saham ing taun iki|VSTM: Wutah bathi resik saben siji saham kanggo taun lumaku|GLUE (Monte Rosa Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Cullinan Oncology CGEM|Wutah bathi ing taun lumaku IMRX|C4 Therapeutics Corp - Wutah bathi saben saham ing taun iki|Black Diamond - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku RPTX|PMVP: Wutah bathi resik saben saham ing taun iki|Karyopharm Therapeutics - Wutah bathi resik saben siji saham kanggo taun lumaku|BGMS: Wutah bathi ing taun lumaku|Aadi Bioscience, Inc. - Tambahing bathi saben saham ing taun lumaku|ALRN (Aileron Therapeutics Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Blueprint Medicines Corp BPMC|Wutah bathi saben saham ing taun lumaku GlycoMimetics, Inc. (GLYC)|SWTX (SpringWorks Therapeutics Inc.) - Tambahing bathi saben saham ing taun lumaku